Sound Income Strategies’s Adverum Biotechnologies ADVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1
Closed -$5 2514
2025
Q3
$5 Buy
+1
New +$3 ﹤0.01% 1690
2024
Q1
Sell
-1
Closed -$8 1353
2023
Q4
$8 Buy
+1
New +$9 ﹤0.01% 1310

Sound Income Strategies's ADVM Position: Q4 2025 in Review

Sound Income Strategies sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 1 share — an estimated $5 sold.

Sound Income Strategies first reported a position in ADVM in Q4 2023 and held it in 2 quarters. The position peaked at $8 in Q4 2023. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.

  • Sound Income Strategies reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
  • Sound Income Strategies sold 1 Adverum Biotechnologies share in Q4 2025, an estimated $5.
  • Sound Income Strategies first reported a position in Adverum Biotechnologies in Q4 2023 and held it in 2 quarters.
  • Sound Income Strategies's Adverum Biotechnologies position peaked at $8 in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.

Based on Sound Income Strategies's 13F filing for Q4 2025, filed 21 Jan 2026.